Skip to main content

Antivirals for Pandemic Influenza Guidance on Developing a Distribution and Dispensing Program (2008) / Chapter Skim
Currently Skimming:

Appendix D: Meeting Two Agenda
Pages 113-116

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 113...
... Appendix D Meeting Two Agenda Committee on Implementation of Antiviral Medication Strategies for an Influenza Pandemic Meeting 2 January 7, 2008 Keck Center of The National Academies 500 Fifth Street, NW Room 110 Washington, DC 20001 (live audio/video feed provided in Room 105) 10:00 am Influenza Antivirals and Their Use: Effectiveness, Resistance, Surveillance Alexander Klimov Chief, Virus Surveillance and Diagnosis Branch Influenza Division Centers for Disease Control and Prevention 10:20 am Mathematical Modeling of Resistance in a Pandemic Marc Lipsitch Professor of Epidemiology Department of Epidemiology Department of Immunology and Infectious Diseases Harvard School of Public Health 10:40 am Committee Questions and Discussion 113
Read the entire page →
From page 114...
... 114 ANTIVIRALS FOR PANDEMIC INFLUENZA 11:00 am Antiviral Distribution Planning: More from State Public Health Agencies Paul Jarris Executive Director Association of State and Territorial Health Officials 11:15 am Committee Questions and Discussion 11:30 am Lessons from Past Public Health Drug or Vaccine Distribution Campaigns: Swine Flu Immunization Program, Vaccine Shortage, Antibiotic Distribution After Anthrax Attacks Swine Flu Walter Dowdle Senior Consultant to World Health Organization Polio Eradication Program Task Force on Child Survival and Development 11:45 am Lunch 12:45 pm Lessons from Past Public Health Drug or Vaccine Distribution Campaigns (continued) Influenza Vaccine Shortage Claire Hannan Executive Director Association of Immunization Managers Anthrax Eddy Bresnitz Deputy Health Commissioner State Epidemiologist New Jersey Mary Mahoney Bioterrorism Coordinator North Shore–Long Island Jewish Health System New York 1:30 pm Committee Questions and Discussion
Read the entire page →
From page 115...
... Stephen Jones Cluster Occupational Health Manager Downstream and Chemicals ExxonMobil Corporation Michael McGuire Vice President Roche Laboratories, Inc. 4:00 pm Committee Questions and Discussion
Read the entire page →
From page 116...
... In a Publicly Funded Health Care System Victoria Davey Deputy Chief, Public Health and Environmental Hazards Officer Veterans Health Administration Department of Veterans Affairs In a Private Health Care System Skip Skivington Vice President of Supply Chain and Director of Operations, Procurement and Supply Program Offices Kaiser Permanente Eric Koscove Chief Emergency Department Kaiser Permanente Medical Center Santa Clara, CA 5:35 pm Committee Questions and Discussion 5:50 pm Public Comment (if time allows) 6:00 pm Adjourn
Read the entire page →

Key Terms

  • kaiser permanente
  • veterans health
  • private health
  • health administration
  • permanente medical

  • public comment
  • cluster occupational
  • hazards officer
  • funded health
  • santa clara

  • publicly funded
  • occupational health
  • health manager
  • time allows
  • environmental hazards

  • deputy chief
  • supply chain
  • public health
  • health care
  • vice president

  • exxonmobil corporation
  • veterans affairs
  • stephen jones
  • roche laboratories
  • emergency department

  • program offices
  • eric koscove
  • medical center
  • michael mcguire
  • skip skivington


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.